There have been a number of studies showing that blue (temperature) light stimulates dopamine phasis (post-synaptic responses) in rodents and drosophila. Does anyone know about how this works? Surely light is processed by the eye, and the DA reaction is secondary?

The question is an important one because psychopharmacology can reduce DA synthesis and block receptors, and while this is useful for reducing presynaptic (tonic) overregulation and associated positive symptoms, but it does the opposite for post-synaptic (phasis) - and this is predicted to make negative signs only worse (Golembiewski 2013). What's curious is that in my research I've found anecdotes that suggest that schizophrenia patients have a preference for blue light (this has to be confirmed using controlled studies). The idea of using light therapy is appealing, not only because it promises to address a failure of pharmacological agents, but also because it's use will be non-invasive and cheap. But again, how does it all work? Any ideas?

Golembiewski, Jan. (2013). The subcortical confinement hypothesis for schizotypal hallucinations. Curēus, 5 (5), e118. doi: 10.7759/cureus.118

Similar questions and discussions